Home
Conditions
TDP-43 Proteinopathies

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

870 public trials 211 recruiting studies

Refine in advanced search Browse all conditions

TDP-43 Proteinopathies trial results

Recruiting

Language in Primary Progressive Aphasia

NCT00537004

Conditions: Aphasia, Aphasia, Primary Progressive, Brain Diseases, +21 more
Locations: Northwestern University Chicago, Illinois, United States

View Trial Details

Recruiting

Alleviating Persistent Dyspnea in Amyotrophic Lateral Sclerosis Patients Treated With Non-Invasive Ventilation Through Immersive Virtual Reality

NCT06021938

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Service de Pneumologie Paris, France

View Trial Details

Recruiting

Speech and Language Interventions for Italian People With PPA

NCT06739967

Conditions: Aphasia, Aphasia, Primary Progressive, Brain Diseases, +21 more
Locations: Istituti Clinici Scientifici Maugeri IRCCS Bari, Italy

IRCCS Ospedale San Raffaele Milan, Italy

View Trial Details

Recruiting

Evaluation of the Combined Therapy of EH-301 and N-acetylcysteine Together With Riluzole in Amyotrophic Lateral Sclerosis (ALS)

NCT07414212

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Hospital Universitario Donostia San Sebastián, Guipuzcoa, Spain

View Trial Details

Recruiting

Assessing Perceptual Effects of Interactive Tasks

NCT06828523

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Speech Core, Pennsylvania State University University Park, Pennsylvania, United States

View Trial Details

Recruiting

Safety and Tolerability Study of CTx1000 In Participants With Amyotrophic Lateral Sclerosis

NCT07401121

Conditions: ALS (Amyotrophic Lateral Sclerosis), Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +9 more
Locations: Macquarie University Hospital Sydney, New South Wales, Australia

View Trial Details

Recruiting

Intermuscular Coherence as a Biomarker for ALS

NCT05104710

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: University of California Center for Clinical Research Irvine, California, United States

University of Miami Miller School of Medicine Miami, Florida, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Washington University Medical Center St Louis, Missouri, United States

View Trial Details

Recruiting

Needs of ALS Patients With C9orf72 Mutation and Their Caregivers

NCT07302321

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Istituto Auxologico Italiano IRCCS Milan, Lombardy, Italy

IRCCS Ospedale San Raffaele Milan, Italy

IRCCS Fondazione Mondino, Istituto Neurologico Nazionale a Carattere Scientifico Pavia, Italy

View Trial Details

Recruiting

Retinal Imaging in Neurodegenerative Disease

NCT03233646

Conditions: APOE-4 Positive, Abnormalities, Multiple, Alzheimer Disease, +65 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Recruiting

Quantification of Hsp90 in the Human Brain

NCT07380204

Conditions: Alzheimer Disease, Alzheimer's Disease (AD), Amyotrophic Lateral Sclerosis, +22 more
Locations: UZ Leuven Leuven, Vlaam-Brabant, Belgium

View Trial Details

TDP-43 Proteinopathies

TDP-43 Proteinopathies trial results

Related conditions